Reagan Jarvis | BiotechTV

top of page

Sweden's Annoca announced a $46M raise last month to help move its first TCR-T program into the clinic for KRAS-driven pancreatic cancer. CEO Reagan Jarvis tells us about that work and more.

He describes the raise and the trial, which is an umbrella study that will test products against three different mutations. Plus, work on...

Company News

Sep 18

Sweden's Anocca is a TCR-T company with a unique approach that is going after unique targets, its first CTA will be filed soon

Co-Founder and CEO Reagan Jarvis describes Anocca's TCR mapping, discovery, and engineering approach, as well as why they have chosen...

Company News

Sep 21, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page

Sweden's Annoca announced a $46M raise last month to help move its first TCR-T program into the clinic for KRAS-driven pancreatic cancer. CEO Reagan Jarvis tells us about that work and more.

Sweden's Anocca is a TCR-T company with a unique approach that is going after unique targets, its first CTA will be filed soon

Follow BiotechTV

Sponsors

Sponsor Spotlight